Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Biosergen’s application to start human clinical trials with BSG005 is approved

Tuesday, August 24, 2021: Biosegen  AB (“Biosergen” or the “Company”) today announced that it has received positive feed back from the Australian regulatory authorities on the  application to initiate a phase I study in Austrialia of the Company’s proprietary antifungal drug candidate BSG005. With the approval, Biosergen is ready to conduct its First in Man clinical trial with BSG005.Biosergen submitted the application for the clinical phase I safety and tolerability study in 72 healthy male volunteers in Australia in May. The trial is so-called a single ascending dose and a multiple

Prostatype ® P-score and prognostic evaluation in Prostate cancer to be presented at the largest Urology meeting in the world

-Results of the study from Skåne University Hospital selected to present during American Urology Congress 2021The American Urology Association congress 2021 is the largest and most important gathering of Urologists in the world, and Prostatype Genomics is very proud to share that one of our P-score clinical validation studies has been selected for presentation at the congress. Lidi Xu, Chief Technology Officer at Prostatype Genomics comments “We are very happy to have received this nomination; over- and under- treatment of prostate cancer patients is common, and a significant problem for

Traction gas springs – a new highly requested product group

Lesjöfors' product range is growing continuously. We can now also offer traction gas springs that provide immediate power and high safety in applications that require a controlled closing. The products are available both in the standard range and as well as custom-made adapted to individual requirements.A traction gas spring is different from a conventional gas spring since it is working in the opposite direction, which means that it contracts instead of being pushed out. Unloaded, the piston rod is inside the cylinder while as under load; the force works to pull the rod back into the

Clavister Appoints Specialist Camilla Törnblom as Marketing Director, Building a Solid Platform for Marketing

August 24, 2021 – Örnsköldsvik, Sweden – Clavister , a leader in high-performance cybersecurity solutions, today announces it has appointed specialist Camilla Törnblom as Marketing Director. To bring Clavister closer to its customers and partner, the company formed a new commercial department under the leadership of Chief Commercial Officer, Przemek Sienkiewicz. As part of that strategy, Törnblom joins to head the new marketing team, where she’ll be responsible for executing Clavister’s

The Finnish Financial Supervisory Authority has approved a supplement to the prospectus prepared for the merger of Altia Plc and Arcus ASA

ALTIA PLC      STOCK EXCHANGE RELEASE    24 August 2021 AT 11:00 a.m. EEST THIS STOCK EXCHANGE RELEASE MAY NOT BE PUBLISHED OR DISTRIBUTED, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION OR DISTRIBUTION WOULD VIOLATE APPLICABLE LAWS OR RULES OR WOULD REQUIRE ADDITIONAL DOCUMENTS TO BE COMPLETED OR REGISTERED OR REQUIRE ANY MEASURE TO BE UNDERTAKEN IN ADDITION TO THE REQUIREMENTS UNDER FINNISH LAW. FOR FURTHER INFORMATION, SEE “IMPORTANT NOTICE” BELOW. The Finnish Financial

Arcus: The Finnish Financial Supervisory Authority has approved a supplement to the prospectus prepared for the merger of Altia Plc and Arcus ASA

THIS STOCK EXCHANGE RELEASE MAY NOT BE PUBLISHED OR DISTRIBUTED, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION OR DISTRIBUTION WOULD VIOLATE APPLICABLE LAWS OR RULES OR WOULD REQUIRE ADDITIONAL DOCUMENTS TO BE COMPLETED OR REGISTERED OR REQUIRE ANY MEASURE TO BE UNDERTAKEN IN ADDITION TO THE REQUIREMENTS UNDER FINNISH LAW. FOR FURTHER INFORMATION, SEE “IMPORTANT NOTICE” BELOW. Arcus: The Finnish Financial Supervisory Authority has approved a supplement to the prospectus prepared

SMART WIRES ANNOUNCES NEW CFO AND EXPANDED LEADERSHIP TEAM

San Francisco, US: Global power technology company, Smart Wires is pleased to announce the appointment of Julie Andrews to the position of Chief Financial Officer, and further appointments to its Leadership team.Smart Wires’ innovative technology is gaining huge traction across the world, enabling system operators to control power flows and maximize the grid’s capacity for renewables. To continue to support the strong momentum it is seeing across key markets, the company has significantly strengthened its senior leadership team over the last quarter. Smart Wires has complemented its

Valmet to supply a multifuel boiler to Kipaş Kağit Sanayi Isletmeleri A.Ş.’s paper mill in Turkey

Valmet Oyj’s press release on August 24, 2021 at 11:00 a.m. EETValmet will supply a multifuel power boiler and auxiliary process equipment to Kipaş Kağit Sanayi Isletmeleri A.Ş.’s paper mill in Kahramanmaraş, Turkey. The new boiler will improve the reliability of the paper mill’s steam and electricity supply. Additionally, its steam production capacity will be sufficient for the mill’s future paper machine PM 4. The order was included in Valmet’s orders received of the second quarter 2021. Typically, the value of this kind of order is in the range of EUR 25–35 million. The boiler plant

Karstensens Shipyard again selects Wärtsilä propulsion solutions for newbuild fishing vessels

Wärtsilä Corporation, Press release, 24 August 2021 at 10.30 AM EESTThe technology group Wärtsilä’s strong relationship with the Danish ship builder Karstensens Shipyard is once again emphasised with main propulsion equipment orders for two new fishing vessels. During the past year alone, the Karstensens yard has selected Wärtsilä solutions for seven vessels. These latest orders were placed in July. A custom designed 77-metre overall length fishing vessel, the ‘Christina S’, will be owned and operated by the Fraserburgh, Scotland based Simpson family’s Christina S Fishing Company in

Capital increase in TORM due to exercise of Restricted Share Units as part of the Company’s incentive program

TORM plc (“TORM”) increases its share capital by 54,905 A-shares (corresponding to a nominal value of USD 549.05) as a result of the exercise of a corresponding number of Restricted Share Units. The capital increase is carried out without any pre-emption rights for existing shareholders or others. 54,905 of the new shares have been subscribed for in cash at DKK 43.4 per A-share, all with a nominal value of USD 0.01 each. The new shares are ordinary shares without any special rights and are negotiable instruments. The new shares give right to dividends and other rights in relation to

InDex Pharmaceuticals receives FDA clearance to start the phase III study CONCLUDE with cobitolimod

August 24, 2021 – InDex Pharmaceuticals Holding AB (publ) today announced that the U.S. Food and Drug Administration (FDA) has given clearance to start the phase III clinical study CONCLUDE in the United States. The study will evaluate the efficacy and safety of the first-in-class TLR9 agonist cobitolimod for the treatment of moderate to severe left-sided ulcerative colitis.“The United States is the largest pharmaceutical market in the world, and to receive clearance from the FDA  to start the phase III study CONCLUDE with cobitolimod is an important milestone for InDex,” said Peter

Proven long-term effect for Dicot’s drug candidate

Press release: Uppsala, August 24, 2021. The pharmaceutical company Dicot now releases results from its latest animal study concluding that the drug candidate LIB-01 has a longer effect on erectile function than other drugs on the market today, and that the effect increases over time. The study outcome is a significant milestone for the LIB-01 project.As previously reported Dicot is conducting animal studies in collaboration with the French contract laboratory Pelvipharm, where the drug candidate LIB-01's effect on erectile function is tested in both healthy rats and in animal disease

Resurs Bank to launch direct payment solutions through its partnership with Trustly

Resurs Bank is launching direct bank payments in the Nordic market through a new partnership with Trustly. With Trustly, consumers will be able to make easy direct banking payments from any account via their internet bank. The service will be available in the Resurs Checkout solution that combines all payment methods in the same integration. The partnership fits well with broadening Resurs’s goal of offering simple ways to make direct payments.“For our customers to remain satisfied, we need to be sensitive to existing and new needs for simple payment solutions. With Trustly, which is a

Södra’s green investment continues – with switch to recycled material in packaging

Södra’s investment in circularity continues. Through a new partnership with Swedish company Trioworld, Södra’s timber packaging will now contain 30 percent recycled plastic, which will reduce annual emissions from the packaging by around 23 percent.“With the new packaging, we are ensuring high-quality deliveries for our customers, while also taking an additional step towards a more circular business model with lower emissions. This is a trend we will continue to pursue. On the challenges with sustainability, there is no finish line to pass and we are constantly working to be the market

Global initiative formed to push responsible and circular electronics

More than 20 organizations have come together in a global initiative to tackle the social and environmental problems of electronics. The Circular Electronics Initiative aims to encourage organizations and consumers to take a more responsible approach to the electronic goods they use. One core activity of the initiative is the annual event #CircularElectronicsDay.“#CircularElectronicsDay  has now been running for a few years and has attracted a lot of attention, and we feel that more can be done. This is not an issue just one day of the

Safello Subscription Opens up for Public Beta

Stockholm, 24 August 2021 | Swedish fintech Safello  today announced that the development and testing of Safello Subscription is going according to plan and that the company is now moving from its closed private beta programme to open up to external users. Safello Subscription is an upcoming service that allows customers to purchase cryptocurrency on a recurring basis, where users effortlessly can set up a savings plan in Bitcoin and Ethereum. The service, which is scheduled to be offered to the public in the second half of 2021, began a closed private beta

Idogen publishes interim report for 1 January – 30 June 2021

Idogen AB's interim report for January to June 2021 is available on the company's website https://idogen.com/en/investors/financial-reports/   Second quarter (April-June 2021) •    Other operating income amounted to KSEK 1,731 (2,782)•    Operating loss was KSEK -9,514 (-7,292)•    Loss for the period totaled KSEK -9,604 (-7,976)•    Cash flow from operating activities was KSEK -6,135 (-9,003)•    Loss per share before dilution was SEK -0.53 (-0.87) Loss per share after dilution was SEK -0.53 (-0.87) Period (January-June 2021)•    Other operating income amounted to

Martin Olin becomes CEO of Norwegian BerGenBio – continues as chairman for AcouSort

AcouSort's Chairman of the Board, Martin Olin, has been appointed CEO of the Norwegian biotechnology company BerGenBio ASA. Martin Olin will take up his new position on September 8 this year. Martin Olin will also continue his role as Chairman of the Board of AcouSort.On April 28 this year, Martin Olin was appointed Chairman of the Board of AcouSort. Now, he has also been appointed CEO of the Norwegian biotechnology company BerGenBio ASA. In parallel, he will continue his engaged work leading AcouSort's board. - We congratulate Martin Olin on his new position at BerGenBio. The fact that

MTG’s Lars Torstensson will step down from CFO role and remain as EVP Communications & Investor Relations

STOCKHOLM, August 24, 2021 — Modern Times Group MTG AB’s (MTG) today announces changes to its executive management. Lars Torstensson has decided to step down from his position as CFO at his own request due to personal and family reasons but will remain with the company as EVP Communications & IR and continue to serve on the Executive Management Team.MTG’s CFO and EVP Communications & IR Lars Torstensson, has decided to step down from his current position as CFO at his own request due to personal and family reasons. However, he will remain in the role of EVP Communications & IR and continue

Spago Nanomedical interim report January-June 2021

Continued good pace in the business despite Covid-19 APRIL – JUNE IN BRIEF · Net sales for the quarter amounted to KSEK 267 (KSEK 0). · The loss for the quarter amounted to KSEK -11,607 (KSEK -4,764). · Operating expenses for the quarter amounted to KSEK -13,450 (KSEK -6,269). · Earnings per share, before and after dilution, for the quarter amounted to SEK -0.28 (SEK -0.19). · Cash and cash equivalents at the end of the quarter amounted to KSEK 76 873 (KSEK 41,421). JANUARY – JUNE IN BRIEF · Net sales for the half-year period amounted to KSEK 367 (KSEK 100). ·

Lipidor publishes interim report for H1 2021

STOCKHOLM, Sweden, 24[th] August 2021: Today, Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) publishes its interim report for the period January – June 2021. The quarterly report is available on the company's website (click here ) and in the attached pdf (in Swedish).Summary of the interim report – second quarter 2021 Lipidor has had an intense first half year with success in many areas. At the beginning of the year, we signed a license agreement with Cannassure Therapeutics (for topical medical cannabis products based on

One million Baltic herring fish fingers will be eaten on Baltic Sea Day - Apetit’s new frozen food product is smart fish choice of this fall

Apetit Oyj, press release 24 August 2021 9.00 a.m.Apetit’s new frozen food product for this fall is Baltic Sea Fish Fingers, made from Finnish Baltic herring fillet. Baltic herring is a sustainable fish choice, and it decreases Baltic Sea’s nutrient load. Over 1 million Baltic Sea Fish Fingers will be eaten on Baltic Sea Day 26 August, when fish fingers are on the menu in many schools and nurseries. The product will be available in retail in September-October. Apetit Baltic Sea Fish Fingers are made from Finnish MSC-certified Baltic herring (56%). The fish fingers have a gluten-free

Warrants of series TO1 were subscribed to approximately 94.1 percent and Pharmacolog i Uppsala AB (publ) receives approximately SEK 21.4 million

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER TO IMPORTANT INFORMATION AT THE END OF THE PRESS RELEASE.Pharmacolog i Uppsala AB (publ) (”Pharmacolog” or the ”Company”) announces today the outcome of the exercise of warrants of series TO1, which were issued during the second

Interim Report Q2 – April – June, 2021 Redsense Medical AB (publ)

Second quarter, 1 April – 30 June 2021 The Redsense Group · Net sales amounted to kSEK 1,059 (5,292), an 80 percent decrease compared with the corresponding period in 2020. · Profit or loss before tax amounted to kSEK -3,833 (93). First half-year, 1 January – 30 June 2021 The Redsense Group · Net sales amounted to kSEK 2,205 (10,202), a 78 percent decrease compared with the corresponding period in 2020. · Profit or loss before tax amounted to kSEK -4,358 (371). · Total equity amounted to kSEK 41,146 at the end of the period. · Cash and cash equivalents

There are no items matching the current filter
There are no more items matching the current filter
Back to top